Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF.

[1]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[2]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[3]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[4]  B. Vandermeer,et al.  Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction , 2007, Annals of Internal Medicine.

[5]  K. Schulman,et al.  Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. , 2007, JAMA.

[6]  C. O'connor,et al.  Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. , 2007, American heart journal.

[7]  J. Bradfield,et al.  Low Referral Rate for Prophylactic Implantation of Cardioverter‐Defibrillators in a Tertiary Care Medical Center , 2009, Pacing and clinical electrophysiology : PACE.

[8]  A. Kadish,et al.  Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy. , 2005, Circulation.

[9]  J. Ruskin,et al.  Implantable Cardioverter Defibrillator Utilization Based on Discharge Diagnoses from Medicare and Managed Care Patients , 2002, Journal of cardiovascular electrophysiology.

[10]  C. O'connor,et al.  Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF , 2008, Circulation. Heart failure.

[11]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[12]  C. Yancy,et al.  Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. , 2007, JAMA.

[13]  C. Albert,et al.  Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. , 2008, American heart journal.

[14]  K. Ellenbogen,et al.  Gender Disparity in the Use of Cardiac Resynchronization Therapy in the United States , 2008, Pacing and clinical electrophysiology : PACE.

[15]  M. Komajda,et al.  Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey , 2007, European journal of heart failure.